↓ Skip to main content

Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis

Overview of attention for article published in Frontiers in immunology, May 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Exploring the Role of Medicinal Plant-Based Immunomodulators for Effective Therapy of Leishmaniasis
Published in
Frontiers in immunology, May 2014
DOI 10.3389/fimmu.2014.00193
Pubmed ID
Authors

Garima Chouhan, Mohammad Islamuddin, Dinkar Sahal, Farhat Afrin

Abstract

Leishmaniasis is a pestilent affliction that importunately needs better therapeutics necessitated by the absence of effective vaccine, emergence as HIV co-infection, and the dread of debilitating chemotherapy. The Leishmania parasites incapacitate host macrophages by preventing the formation of phagolysosomes, impeding antigen presentation to T cells, leading to suppression of cell-mediated immunity. An ideal approach to cure leishmaniasis includes administration of antileishmanial compounds that can concomitantly establish an effective Th1 response via restoration of requisite signaling between macrophages and T cells, for subsequent activation of macrophages to eliminate intracellular amastigotes. Plants have provided an opulent treasure of biomolecules that have fueled the discovery of antileishmanial drugs. Modulation of immune functions using medicinal plants and their products has emerged as an effective therapeutic strategy. Herein, we review the plant extracts and natural products that have resulted in therapeutic polarization of host immunity to cure leishmaniasis. These immunostimulatory phytochemicals as source of potential antileishmanials may provide new strategies to combat leishmaniasis, alone or as adjunct modality.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Brazil 1 1%
Unknown 88 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 12%
Researcher 11 12%
Student > Master 11 12%
Student > Bachelor 10 11%
Student > Doctoral Student 6 7%
Other 21 23%
Unknown 20 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 20 22%
Pharmacology, Toxicology and Pharmaceutical Science 8 9%
Biochemistry, Genetics and Molecular Biology 7 8%
Chemistry 7 8%
Medicine and Dentistry 5 6%
Other 21 23%
Unknown 22 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2014.
All research outputs
#22,756,649
of 25,371,288 outputs
Outputs from Frontiers in immunology
#27,412
of 31,513 outputs
Outputs of similar age
#209,436
of 241,897 outputs
Outputs of similar age from Frontiers in immunology
#124
of 150 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,513 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,897 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.